• Email Us: [email protected]
  • Contact Us: +1 718 618 4351
  • Skip to content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Taliban will be judged on deeds, says U.S., after ‘candid and professional’ talks

October 11, 2021 by David Barret Leave a Comment

October 11, 2021

WASHINGTON (Reuters) – The United States said on Sunday that talks in the first face-to-face meeting between senior U.S. and Taliban officials since the hardline group retook power in Afghanistan in August were “candid and professional”.

But the U.S. side reiterated that the Taliban would be judged on its actions, not only its words.

A State Department statement said the U.S. delegation in the Doha talks focused on security and terrorism concerns and safe passage for U.S. citizens, other foreign nationals and Afghans, as well as on human rights, including meaningful participation of women and girls in all aspects of Afghan society.

It said the two sides also discussed provision by the United States of robust humanitarian assistance directly to the Afghan people.

(Reporting by David Brunnstrom; Editing by Muralikumar Anantharaman)

Source Link Taliban will be judged on deeds, says U.S., after ‘candid and professional’ talks

Related posts:

  1. Bolsonaro to meet striking Brazil truckers, exporters on edge
  2. LinkedIn doubles down on development with new learning hub, free courses and new search fields for hybrid working
  3. R. Kelly hid crimes in ‘plain sight,’ prosecutor says near end of sex trafficking trial
  4. UK regulator demands video platforms do more to protect users

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar


  • Home
  • All Reports
  • About Us
  • Contact Us
  • +1 718 618 4351
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2022 · Medical Market Report. All Rights Reserved.

Go to mobile version